
Aiforia Technologies
3.6
EUR
-2.17 %
AIFORIA
First North Finland
Medical Equipment & Services
Health Care
1,793 following
-2.17%
+0.28%
+2.56%
-6.25%
-20.35%
-4%
-27.57%
-
-28.85%
Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.
Read moreMarket cap
104.09M EUR
Turnover
51.66K EUR
P/E (adj.) (24e)
-8.66
EV/EBIT (adj.) (24e)
-8.14
P/B (24e)
6.63
EV/S (24e)
29.18
Dividend yield-% (24e)
-
Coverage
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7/3
2025
Annual report '24
4/4
2025
General meeting '25
28/8
2025
Interim report Q2'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types


Aiforia, Webcast, Q4'24
Aiforia CEO increased shareholding in the company in January
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Aiforia selected as partner for major regional health region in Italy
Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy
Aiforia Technologies Plc – Managers' Transactions
Aiforia Technologies Plc – Managers' Transactions

Aiforia as an Investment | Life Science Night Dec. 2, 2024
Life Science Night available on inderesTV
Aiforia wins new clinical segment client in Turkey

Life Science Companies as Investments | Life Science Night Dec. 2, 2024
